PHILADELPHIA--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced new preliminary data for AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) in adults aged 18-49 at increased risk for ...

The UAB-SCIMS offers a series of Fact Sheets on selected topics related to SCI. Some Fact Sheets are products of the University of Alabama at Birmingham Spinal Cord Injury Model System (UAB-SCIMS).

Based on data from its AReSVi-006 trial, the British vaccine maker said Arexvy, compared to a placebo, led to an overall ...

GSK (GSK) announced new preliminary data for AREXVY in adults aged 18-49 at increased risk for lower respiratory tract disease, LRTD, caused by respiratory syncytial virus due to certain ...

GSK's major growth drivers, Shingrix and Arexvy, along with recent legal progress, make its current undervaluation ...

Who made the first cars? Beginning in the 1770s, many people tried to make cars that would run on steam. Some early steam cars worked well, and some did not. Some were fire pumpers that moved by ...

GSK announced on Tuesday that a single dose of its Arexvy vaccine against respiratory syncytial virus (RSV) was 43.3% effective in preventing severe illness three years after patients 60 and older ...

Getty Images / Pekic A company's financial statements—balance sheet, income, and cash flow statements—are a key source of data for analyzing the investment value of its stock. Stock investors ...

Yarilet Perez is an experienced multimedia journalist and fact-checker with a Master of ... The Fed uses its balance sheet to help it accomplish those goals. The Fed decides what assets it holds ...

With the arrival of fall also comes the arrival of respiratory illness season, a time when many are at increased risk of ...

People who live in states that observe daylight saving time will see more daylight in the mornings and darker evenings as we “fall back.” Many VERIFY readers have sent us questions about ...